These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 12430546)
21. Motion sickness and its prevention by drugs. Brand JJ Curr Med Drugs; 1967 Aug; 7(12):17-26. PubMed ID: 6064966 [No Abstract] [Full Text] [Related]
22. Appropriateness of kaolin consumption as an index of motion sickness in the rat. McCaffrey RJ Physiol Behav; 1985 Aug; 35(2):151-6. PubMed ID: 4070378 [TBL] [Abstract][Full Text] [Related]
27. Pica as an index of motion sickness in rats. Morita M; Takeda N; Kubo T; Matsunaga T ORL J Otorhinolaryngol Relat Spec; 1988; 50(3):188-92. PubMed ID: 3261413 [TBL] [Abstract][Full Text] [Related]
28. Coping with space motion sickness in Spacelab missions. Graybiel A Acta Astronaut; 1981; 8(9-10):1015-8. PubMed ID: 11543090 [TBL] [Abstract][Full Text] [Related]
29. [Comparative in-flight study of a scopolamine-containing membrane plaster versus dimenhydrinate under defined acceleration conditions]. Offenloch K; Zahner G; Dietlein G; Franz I Arzneimittelforschung; 1986 Sep; 36(9):1401-6. PubMed ID: 3539128 [TBL] [Abstract][Full Text] [Related]
30. Neuropharmacological mechanisms of emesis. I. Effects of antiemetic drugs on motion- and apomorphine-induced pica in rats. Takeda N; Hasegawa S; Morita M; Horii A; Uno A; Yamatodani A; Matsunaga T Methods Find Exp Clin Pharmacol; 1995 Nov; 17(9):589-90. PubMed ID: 8786672 [TBL] [Abstract][Full Text] [Related]
32. [Prevention of motion sickness with a transdermal therapeutic system containing scopolamine. A randomized, comparative double-blind study in the German Federal Navy]. Becker G; Goossens H; Seemann K; Souchon F; Weitz T Dtsch Med Wochenschr; 1984 Dec; 109(49):1881-5. PubMed ID: 6499689 [TBL] [Abstract][Full Text] [Related]
33. Motion sickness in cats: a symptom rating scale used in laboratory and flight tests. Suri KB; Crampton GH; Daunton NG Aviat Space Environ Med; 1979 Jun; 50(6):614-8. PubMed ID: 475712 [TBL] [Abstract][Full Text] [Related]
35. Comparison of treatment strategies for Space Motion Sickness. Davis JR; Jennings RT; Beck BG Microgravity Q; 1992 Jul; 2(3):173-7. PubMed ID: 11541442 [TBL] [Abstract][Full Text] [Related]
36. Motion sickness-induced pica in the rat. Mitchell D; Laycock JD; Stephens WF Am J Clin Nutr; 1977 Feb; 30(2):147-50. PubMed ID: 556878 [TBL] [Abstract][Full Text] [Related]
37. A comparison of some effects of three antimotion sickness drugs on nystagmic responses to angular accelerations and to optokinetic stimuli. Collins WE; Schroeder DJ; Elam GW Aviat Space Environ Med; 1982 Dec; 53(12):1182-9. PubMed ID: 7159338 [TBL] [Abstract][Full Text] [Related]
38. [Motion sickness and its treatment (author's transl)]. Petrin A Schweiz Rundsch Med Prax; 1974 Jan; 63(3):79-81. PubMed ID: 4153225 [No Abstract] [Full Text] [Related]
39. Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications. Nachum Z; Shupak A; Gordon CR Clin Pharmacokinet; 2006; 45(6):543-66. PubMed ID: 16719539 [TBL] [Abstract][Full Text] [Related]
40. Vestibular evoked myogenic potentials and motion sickness medications. Tal D; Shemy S; Kaminski-Graif G; Wiener G; Hershkovitz D Clin Neurophysiol; 2016 Jun; 127(6):2350-4. PubMed ID: 27178852 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]